Expression of Fibroblast Activation Proteins in Corneal Stromal Neovascularization

被引:14
作者
Wang, Ting [1 ,2 ]
Shi, Weiyun [1 ]
机构
[1] Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao 266071, Peoples R China
[2] Qingdao Univ, Coll Med, Qingdao 266071, Peoples R China
基金
中国国家自然科学基金;
关键词
corneal neovascularization; corneal stroma; factor; GROWTH-FACTOR; SERINE-PROTEASE; XENOGRAFT MODEL; KRINGLE; 1-3; ANGIOGENESIS; CANCER; INHIBITION; CELLS; VEGF;
D O I
10.1080/02713680802607732
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To observe changes of the factors in corneal stroma during corneal neovascularization and to investigate the mechanism of corneal neovascularization. Methods: Forty-eight Wister rats were used, including eight in the control group. Corneal neovascularization was induced by alkali burns in 40 rats. Frozen sections, which were cut across the corneal center, were prepared on days 1, 3, and 7 post-burn, respectively. Transforming growth factor- 1 (TGF- 1) was examined by immunohistochemistry, and fibroblast activation protein (FAP) and a-smooth muscle actin (a-SMA) were detected by double-labeling fluorescent immunohistochemistry. Blood vessel endothelium was identified for PECAM-1 (CD31). Expressions of FAP in the cornea with or without neovascularization were monitored with reverse transcription-polymerase chain reaction on days 3 and 7. Results: In the alkali-burned eyes, TGF-ss1 first expressed in the corneal stroma, and some stromal cells expressed a-SMA and FAP. The FAP+ keratocytes were found around the CD31+ endothelium of angiogenesis. FAP was expressed in the corneas with neovascularization, but not in those without neovascularization. Conclusion: Factors in corneal stroma may change when corneal neovascularization occurs. The stromal keratocytes can express FAP+ cells surrounding the endothelium of angiogenesis.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 17 条
  • [1] ADAMIS AP, 1991, AM J PATHOL, V139, P961
  • [2] Global expression profiling of fibroblast responses to transforming growth factor-β1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching
    Chambers, RC
    Leoni, P
    Kaminski, N
    Laurent, GJ
    Heller, RA
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (02) : 533 - 546
  • [3] Cheng JD, 2003, CLIN CANCER RES, V9, P1590
  • [4] Cheng JD, 2002, CANCER RES, V62, P4767
  • [5] The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization
    Dell, Susanne
    Peters, Swaantje
    Muether, Philipp
    Kociok, Norbert
    Joussen, Antonia M.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (05) : 1928 - 1937
  • [6] IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature:: A novel mechanism for IL-21
    Jackaman, C
    Bundell, CS
    Kinnear, BF
    Smith, AM
    Filion, P
    van Hagen, D
    Robinson, BWS
    Nelson, DJ
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (10) : 5051 - 5063
  • [7] Jester JV, 1999, INVEST OPHTH VIS SCI, V40, P1959
  • [8] The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF
    Kim, JH
    Kim, JC
    Shin, SH
    Chang, SI
    Lee, HS
    Chung, SI
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 1999, 31 (04) : 203 - 209
  • [9] Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology
    Klenkler, B
    Sheardown, H
    [J]. EXPERIMENTAL EYE RESEARCH, 2004, 79 (05) : 677 - 688
  • [10] Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF)
    Murata, M
    Takanami, T
    Shimizu, S
    Kubota, Y
    Horiuchi, S
    Habano, W
    Ma, JX
    Sato, S
    [J]. CURRENT EYE RESEARCH, 2006, 31 (02) : 171 - 180